Skeletal muscle dysfunction in chronic obstructive pulmonary disease. A statement of the American Thoracic Society and European Respiratory Society.
D045930:Anabolic Agents / Q000627:therapeutic use; D004734:Energy Metabolism / Q000502:physiology; D017079:Exercise Tolerance / Q000502:physiology; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000150:complications / Q000503:physiopathology* / Q000628:therapy; D016040:Lung Transplantation; D018763:Muscle Fatigue / Q000502:physiology; D018482:Muscle, Skeletal / Q000503:physiopathology*; D009135:Muscular Diseases / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D018529:Nutritional Support; D010102:Oxygen Inhalation Therapy
D045930:Anabolic Agents